LEADER 03447nas 2200661-a 450 001 996216105303316 005 20240207170414.0 011 $a2212-1102 035 $a(DE-599)ZDB2677520-7 035 $a(OCoLC)802230270 035 $a(CKB)3460000000023844 035 $a(CONSER)--2012250782 035 $a(EXLCZ)993460000000023844 100 $a20120726a20129999 --- - 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aValue in health regional issues 210 1$aNew York, New York :$cElsevier Inc.,$dİ2012- 215 $a1 online resource 300 $aRefereed/Peer-reviewed 311 $a2212-1099 330 $aValue in Health Regional Issues (ViHRI) is a new scientific journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) to encourage and enhance the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions in Asia, Latin America, Central & Eastern Europe, Western Asia, and Africa. Value in Health Regional Issues, a peer-reviewed publication, is an independent journal (unique ISSN), and is related to Value in Health only in cover design and contents. The scope and mission of Value in Health Regional Issues is consistent with the mission and scope of the Society. Value in Health Regional Issues includes articles on health care policy analysis, outcomes research (clinical, economic, and patient-reported) empirical studies, methodological studies, and articles on health care resources in the region. Health care decision-maker commentaries that stimulate communication between health outcomes researchers and policymakers are welcome. Commentaries are expected to include discussion on how researchers can better respond to the needs of those making clinical and financial decisions in health care. 517 1 $aViHRI 606 $aMedical technology$xEvaluation$vPeriodicals 606 $aRegional planning$xEvaluation$vPeriodicals 606 $aMedical care$xEvaluation$vPeriodicals 606 $aPharmaceutical technology$xEvaluation$vPeriodicals 606 $aBiotechnology$xEvaluation$vPeriodicals 606 $aOutcome Assessment, Health Care 606 $aEconomics, Pharmaceutical 606 $aHealth Resources$xstandards 606 $aRisk Assessment 606 $aMedical care$xEvaluation$2fast$3(OCoLC)fst01013794 606 $aMedical technology$xEvaluation$2fast$3(OCoLC)fst01014750 606 $aRegional planning$xEvaluation$2fast$3(OCoLC)fst01093145 608 $aPeriodical 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 615 0$aMedical technology$xEvaluation 615 0$aRegional planning$xEvaluation 615 0$aMedical care$xEvaluation 615 0$aPharmaceutical technology$xEvaluation 615 0$aBiotechnology$xEvaluation 615 12$aOutcome Assessment, Health Care 615 22$aEconomics, Pharmaceutical 615 22$aHealth Resources$xstandards 615 22$aRisk Assessment 615 7$aMedical care$xEvaluation. 615 7$aMedical technology$xEvaluation. 615 7$aRegional planning$xEvaluation. 712 02$aInternational Society for Pharmacoeconomics and Outcomes Research. 906 $aJOURNAL 912 $a996216105303316 996 $aValue in health regional issues$91892726 997 $aUNISA